PT
ROIV icon

Palantir Technologies’s Roivant Sciences ROIV Stock Holding History

Palantir Technologies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,199,625
Closed -$9.59M – 14
2022
Q4 		$9.59M Sell
1,199,625
-1,050,938
-47% -$5.85M 28.72% 1
2022
Q3 		$7.25M Sell
2,250,563
-749,437
-25% -$2.9M 12.87% 2
2022
Q2 		$12.2M Hold
3,000,000
– – 12.51% 2
2022
Q1 		$14.8M Hold
3,000,000
– – 6.04% 5
2021
Q4 		$30.2M Buy
+3,000,000
New +$25M 13.7% 1

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Palantir Technologies's ROIV Position: Q1 2023 in Review

Palantir Technologies sold out of Roivant Sciences (ROIV) in Q1 2023, closing a stake of 1,199,625 shares — an estimated $9.59M sold.

Palantir Technologies first reported a position in ROIV in Q4 2021 and held it in 5 quarters. The position peaked at $30.2M in Q4 2021. 147 funds tracked by Wall St. Rank hold ROIV as of Q1 2023.

  • Palantir Technologies reported no remaining Roivant Sciences position as of Q1 2023 after selling out during the quarter.
  • Palantir Technologies sold 1,199,625 Roivant Sciences shares in Q1 2023, an estimated $9.59M.
  • Palantir Technologies first reported a position in Roivant Sciences in Q4 2021 and held it in 5 quarters.
  • Palantir Technologies's Roivant Sciences position peaked at $30.2M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2023.

Based on Palantir Technologies's 13F filing for Q1 2023, filed 15 May 2023.